Spots Global Cancer Trial Database for Concomitant Radio-chemotherapy in the Elderly
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Concomitant Radio-chemotherapy in the Elderly
Official Title: Phase II Study Evaluating Treatment With Oral Navelbine and Cisplatin Administered Weekly and Concomitant Radiotherapy in Elderly Patients With no Operable NSCLC
Study ID: NCT01029678
Conditions
Study Description
Brief Summary: The purpose of this study is to evaluate the safety of non small cell lung cancer (NSCLC) treatment with cisplatin and oral vinorelbine administered weekly associated with concomitant radiotherapy in elderly patients.
Detailed Description:
Eligibility
Minimum Age: 70 Years
Eligible Ages: OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
CHU Brest, Brest, , France
Centre Hospitalier GAP, GAP, , France
Département de Pathologie Respiratoire du CHU de Limoges, Limoges, , France
CH de Meaux, Meaux, , France
CHU Reims, Reims, , France
Contact Details
Name: Chrystèle LOCHER, MD
Affiliation: CH Meaux
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
